T1	Participants 71 99	anemic patients with cancer.
T2	Participants 216 255	patients with cancer-associated anemia.
T3	Participants 277 331	Eligible patients were randomly assigned at enrollment
T4	Participants 556 604	Three hundred sixty-five patients were enrolled.
T5	Participants 605 707	One hundred eighty-three patients were assigned to the 40K arm, and 182 were assigned to the 120K arm.
